Immunochina Immunochina is a company that specializes in applying CAR-T technology and gene cell drugs to the treatment of malignant tumors. | ![]() Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. | ![]() Paradigm Diagnostics Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing. | ![]() Divide & Conquer Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy. | ![]() Core Biogenesis Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants. | |
Founding Date | Founding Date 2015 | Founding Date 2018 | Founding Date 2012 | Founding Date 2018 | Founding Date 2020 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations CN HQ | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Phoenix, US HQ | Locations Babraham, GB HQ | Locations Paris, FR HQ Illkirch Graffenstaden, FR |
Employees | Employees 205% increase | Employees 4 | Employees 717% increase | Employees 2 | Employees 293% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 20.6m (over 7 years ago) | Latest funding round $ 16m (about 7 years ago) | Latest funding round $ 15m (almost 7 years ago) | Latest funding round $ 12.5m (over 6 years ago) | Latest funding round $ 11m (about 4 years ago) |
Total funding raised | Total funding raised $ 28.1m | Total funding raised $ 31m | Total funding raised $ 23.9m | Total funding raised $ 12.5m | Total funding raised $ 14.1m |

Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View company
Paradigm Diagnostics is a precision medicine company focused on comprehensive cancer testing.
View company
Divide & Conquer is focused on developing new therapeutics against glioblastoma (grade IV astrocytoma), a particularly lethal form of brain cancer, and other solid tumors with very poor life expectancy.
View company
Core Biogenesis is a biotech company developing a production platform to express recombinant proteins from plants.
View company